Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy M Shefner

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2018
Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-RCarlayne Jackson, Mamede De Carvalho, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Estimation of forced vital capacity using speech acoustics in patients with ALSGabriela M Stegmann, Shira Hahn, Cayla J Duncan, et al.
Toxicology Reports|December 26, 2015
Preclinical Rodent Toxicity Studies for Long Term Use of CeftriaxoneElena Ratti, James D Berry, David J Greenblatt, et al.
Annals of Clinical and Translational Neurology|September 18, 2020
Reply to: Frequent self-assessments in ALS clinical trials: Worthwhile or an unnecessary burden?Seward B Rutkove, Pushpa Narayanaswami, Visar Berisha, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 29, 2023
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trialJeremy M Shefner, Bill Jacobsen, Stuart Kupfer, et al.
Annals of Clinical and Translational Neurology|June 10, 2020
Improved ALS clinical trials through frequent at-home self-assessment: a proof of concept studySeward B Rutkove, Pushpa Narayanaswami, Visar Berisha, et al.
Tomography (Ann Arbor, Mich.)|June 2, 2021
Evaluation of Amyotrophic Lateral Sclerosis-Induced Muscle Degeneration Using Magnetic Resonance-Based Relaxivity Contrast Imaging (RCI)Sudarshan Ragunathan, Laura C Bell, Natenael Semmineh, et al.
Annals of Neurology|February 10, 2021
Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral SclerosisAndrew Hannaford, Nathan Pavey, Mehdi van den Bos, et al.
Annals of Neurology|June 28, 2006
Trial of celecoxib in amyotrophic lateral sclerosisMerit E Cudkowicz, Jeremy M Shefner, David A Schoenfeld, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 8, 2024
Plasma neurofilament analysis in VITALITY-ALSTyrell J Simkins, Stuart Kupfer, Fady I Malik, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2018
Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-RCarlayne Jackson, Mamede De Carvalho, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Estimation of forced vital capacity using speech acoustics in patients with ALSGabriela M Stegmann, Shira Hahn, Cayla J Duncan, et al.
Toxicology Reports|December 26, 2015
Preclinical Rodent Toxicity Studies for Long Term Use of CeftriaxoneElena Ratti, James D Berry, David J Greenblatt, et al.
Annals of Clinical and Translational Neurology|September 18, 2020
Reply to: Frequent self-assessments in ALS clinical trials: Worthwhile or an unnecessary burden?Seward B Rutkove, Pushpa Narayanaswami, Visar Berisha, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 29, 2023
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trialJeremy M Shefner, Bill Jacobsen, Stuart Kupfer, et al.
Annals of Clinical and Translational Neurology|June 10, 2020
Improved ALS clinical trials through frequent at-home self-assessment: a proof of concept studySeward B Rutkove, Pushpa Narayanaswami, Visar Berisha, et al.
Tomography (Ann Arbor, Mich.)|June 2, 2021
Evaluation of Amyotrophic Lateral Sclerosis-Induced Muscle Degeneration Using Magnetic Resonance-Based Relaxivity Contrast Imaging (RCI)Sudarshan Ragunathan, Laura C Bell, Natenael Semmineh, et al.
Annals of Neurology|February 10, 2021
Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral SclerosisAndrew Hannaford, Nathan Pavey, Mehdi van den Bos, et al.
Annals of Neurology|June 28, 2006
Trial of celecoxib in amyotrophic lateral sclerosisMerit E Cudkowicz, Jeremy M Shefner, David A Schoenfeld, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 8, 2024
Plasma neurofilament analysis in VITALITY-ALSTyrell J Simkins, Stuart Kupfer, Fady I Malik, et al.
Pageof 11